Weitz Value Fund IDXX trades
Wallace Weitz
Wallace Weitz IDEXX Laboratories Inc stake
total: 54
Trades details
- Total transactions:
- 3
- New positions:
- 1
- Reduced:
- 2
- Held since:
- 2025 Q1
- Held for:
- 6 quarters
- Latest activity:
- 2025 Q4
According to 2026 Q2 report, Wallace Weitz holds 20,000 IDEXX Laboratories Inc (IDXX) shares with a market value of roughly $10.53M accounting for 1.68% of the overall portfolio. To date, the estimated cost basis is nearly $419.95 for "buy" trades and estimated average "sell" price is $671.26. Weitz Value Fund first purchased IDXX in 2025 Q1, initially acquiring 45,000 shares. Since the initial investment in IDEXX Laboratories Inc (IDXX), Weitz Value Fund has made 2 more transactions.
When did Wallace Weitz buy IDEXX Laboratories Inc (IDXX)?
Wallace Weitz first invested in IDEXX Laboratories Inc (IDXX) in 2025 Q1 at the reported quarter-end price of $419.95 per share.
What's the cost basis of Weitz Value Fund's IDXX stake?
The estimated cost basis for IDEXX Laboratories Inc (IDXX) stake is around $419.95 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $419.95
- Weighted AVG sell price:
- $671.26
Wallace Weitz's historical trades in IDEXX Laboratories Inc
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q4
|
1.78%
|
20,000
|
$676.53
|
$13,530,600
|
-51.81% (-21,500)
|
-1.77%
|
|
2025 Q3
|
3.23%
|
41,500
|
$638.89
|
$26,513,935
|
-7.78% (-3,500)
|
-0.26%
|
|
2025 Q1
|
2.20%
|
45,000
|
$419.95
|
$18,897,750
|
new
|
+2.2%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.